NCT06147375View on ClinicalTrials.gov

Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation

NANot yet recruitingINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
Immune ToleranceImmunosuppressionLiver Transplant; Complications
Interventions
DRUG

Tacrolimus or Cyclosporine A

The protocol of IS withdrawal:Week 1-4 take Tacrolimus (Tac) or Cyclosporine A (CsA) once daily for weeks. Week 5-8 medication reduction to taking Tac / CsA 4 times a week . Week 9-12 reduction to taking Tac/ CsA 3 times a week. Week 13-18 reduction to taking Tac / CsA 2 times a week . Week 19-24 reduction to taking Tac/ CsA once per week. Week 25, the recipients will stop taking Tac/ CsA.

Trial Locations (1)

300192

Tianjin First Central Hospital, Tianjin

All Listed Sponsors
lead

Wei Gao

OTHER

NCT06147375 - Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation | Biotech Hunter | Biotech Hunter